Wednesday, 23 July 2014

CDK4/6 Inhibitors in Metastatic Breast Cancer

In this segment, panelists discuss the excitement generated by novel therapies targeting CDK 4/6 in patients with ER-positive metastatic breast cancer. To view more from this segment, visit...

No comments:

Post a Comment